Wegovy® Pill
Once-daily semaglutide GLP-1 pill option.
14% avg.
About 33 lb average loss vs about 6 lb with placebo in a 64-week study.
Modern weight-loss pills, guided by physician-led care.
Great news—new GLP-1 pill options for weight loss and weight control are becoming available. GLP-1 pill medications may offer another option for some patients. Established non-GLP-1 pill medications remain available as well. Below is a quick look at published weight-loss data for several prescription options.
Personalized. Evidence-Based. Physician Guided.
Featured result
14%
Average body-weight loss reported for Wegovy® pill in a 64-week study, with diet and exercise.
Individual results vary. Medication choice depends on medical history, contraindications, tolerability, access, and physician assessment.
GLP-1 Pill
Other Pill Weight Control Options
Foundayo™
Lilly orforglipron once-daily GLP-1 RA pill.
11.1% avg.
17.2 mg dose: about 24.9 lb average loss in adults without diabetes at 72 weeks.